Table 1

Baseline demographics, clinical characteristics and periprocedural results stratified according to 30-day mortality

VariableSurvivors
(n=199)
Dead
(n=19)
P value
Age, years82±780±80.330
Female89(45)9 (47)0.825
Body surface area, m21.8±0.21.7±0.10.005
Body mass index, kg/m226±522±30.001
STS score5.9±3.98.3±4.40.012
Euroscore 29.4±7.211.3±8.80.300
NYHA class0.527
 II29(15)2 (11)
 III120(60)10(53)
 IV50(25)7 (37)
Heart failure84(42)12(63)0.079
Hypertension133(67)15(79)0.280
Atrial dysrhythmia89(45)11(58)0.271
Previous myocardial infarction76(38)6 (32)0.570
Previous PCI78(39)9 (47)0.487
Previous cardiac surgery93(47)5 (26)0.087
LBBB18(9)2 (11)0.831
Peripheral artery disease66(33)14(74)<0.000
Porcelain aorta21(11)5 (26)0.043
Cerebrovascular disease52(26)6 (32)0.608
Previous cerebrovascular event46(23)6 (32)0.408
Immunocompromised24(12)4 (21)0.263
Diabetes59(30)3 (1.5)0.201
COPD70(35)8 (42)0.547
eGFR, ml/min/1.73 m254±2050±240.055
Previous radiation therapy8 (4)1 (5)0.795
Access0.001
 Transfemoral117(59)5 (26)
 Transaortic27(14)1 (5)
 Transapical55(28)13(68)
Valve type0.206
 Edwards Sapien153(77)17(89)
 CoreValve46(23)2 (11)
Periprocedural results
 Intraoperative mortality6 (2.8)
 Myocardial infarction3 (1.5)3 (16)<0.000
 Cerebrovascular event6 (3)7 (37)<0.000
 Major or life-threatening bleeding5 (2.5)5 (26)<0.000
 PVL moderate to severe18(9)2 (10.5)0.085
 Permanent PM postoperatively17 (8.5)0 (0)
  • Values are mean±SD or n (%)

  • COPD, chronic obstructive pulmonary disease;LBBB, left bundle branch block;NYHA, New York Heart Association; PCI, percutaneous coronary intervention;PM, pacemaker;PVL, paravalvular leakage;STS, society of thoracic surgeons; eGFR, estimated glomerular filtration rate; eGFR, estimated glomerular filtration rate.